Anew Medical, Inc. WENA
0.73 +0.73
Day range unavailable
52-week range unavailable
Financial health
Altman Z-Score
-1.75 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 42.7×
FY 2021 5y median 42.7× FY 2023
P/S 0.0×
FY 2021 5y median 0.0× FY 2023
P/B 5.2×
FY 2021 5y median 5.2× FY 2023
P/FCF -46.2×
FY 2021 5y median -144× FY 2023
EV/EBITDA -45.9×
FY 2021 5y median -69.7× FY 2023
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2023
FCF Yield -2.2%
FY 2021 5y median -0.7% FY 2023
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2023
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2023
ROE 12.0%
FY 2021 5y median 1.1% FY 2023
ROIC -5.0%
FY 2021 5y median -5.0% FY 2023
ROA 6.9%
FY 2021 5y median 1.0% FY 2023
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2023
Operating Income -98.0%
FY 2021 FY 2023
EPS (diluted) 69.3%
FY 2021 FY 2023
Free Cash Flow -104.2%
FY 2021 FY 2023
Financial Health
Current Ratio 0.1×
FY 2021 5y median 0.9× FY 2023
Quick Ratio 0.1×
FY 2021 5y median 1.4× FY 2023
Debt / Equity 0.1×
FY 2021 5y median 0.0× FY 2023
Net Debt / EBITDA -1.1×
FY 2021 5y median -1.1× FY 2023
Interest Coverage 0.0×
FY 2021 5y median 0.0× FY 2023
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-12-31